Patient Characteristics and Clinical Outcomes in a Specialist Hypertension Clinic: A Pragmatic Real-World Single-Center Observational Study [0.03%]
高血压专科门诊患者的特征和临床结局：一项务实的、单中心观察研究
William R Marshall,Henry H L Wu,Sharmilee Rengarajan et al.
William R Marshall et al.
Patients referred to specialist hypertension clinics often have complex disease characterized by secondary causes, treatment resistance and coexisting kidney disease. Real-world outcome data in this setting remain limited. We conducted a re...
Observational Study
Journal of clinical hypertension (Greenwich, Conn.). 2026 Apr;28(4):e70243. DOI:10.1111/jch.70243 2026
The Neutrophil Percentage-to-Albumin Ratio: An Emerging Biomarker Associated With Primary Stroke Risk in Hypertensive Patients [0.03%]
高血压患者中性粒细胞百分比与白蛋白比率与原发性脑卒中的风险关联是一项新兴生物标志物
Longguo Zhao,Vipin Kumar,Megumi Narisawa et al.
Longguo Zhao et al.
Clinical Interpretation of Modest Blood Pressure Changes After SGLT2 Inhibitor Initiation [0.03%]
SGLT2抑制剂治疗后血压轻度变化的临床意义解读
Mehmet Alp Şahin,Osman Karaarslan,Mehmet Mustafa Yılmaz et al.
Mehmet Alp Şahin et al.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated modest blood pressure-lowering effects in patients with diabetes and cardiovascular disease. The recent real-world analysis by Ito et al. investigated blood pressure change...
Diagnostic Testing Patterns Influence the Detected Burden of Hypertension-Mediated Organ Damage in Hospitalized Hypertensive Patients [0.03%]
诊断性检测模式影响住院高血压患者的高血压介导的器官损害负担检测结果
The Dung Bui,Phuc Tai Le,Le Nhat Thanh Dinh et al.
The Dung Bui et al.
Hypertension-mediated organ damage (HMOD) plays a central role in cardiovascular risk stratification, yet real-world implementation of guideline-recommended screening remains heterogeneous across Asian healthcare systems. We conducted a ret...
Takeshi Fujiwara,Masaki Mogi
Takeshi Fujiwara
Effects of Aliskiren Monotherapy on Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Blood Pressure and Urinary Protein Excretion Outcomes [0.03%]
阿利吉仑单药治疗对慢性肾脏病患者血压及尿蛋白排泄的影响：系统性回顾和荟萃分析
N M Mahmudul Alam Bhuiya,Joshua Caballero,Henry N Young et al.
N M Mahmudul Alam Bhuiya et al.
Aliskiren has been proposed as an alternative for renin-angiotensin system blockage in chronic kidney disease (CKD); however, its efficacy and safety remain uncertain. The objective of this study was to evaluate the antihypertensive and ant...
Effect of Modular Training on Self-Management, Disease, and Treatment Adaptation in Individuals With Hypertension: A Randomized Controlled Trial [0.03%]
模块化培训对高血压患者自我管理、疾病和治疗适应效果的随机对照试验
Esra Keşer,Derya Atik,Ulviye Özcan Yüce
Esra Keşer
Hypertension requires sustained self-management, behavioral adaptation, and effective patient education. Individuals often experience insufficient knowledge, low motivation, and difficulty maintaining treatment behaviors. This randomized co...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2026 Mar;28(3):e70238. DOI:10.1111/jch.70238 2026
Cesare Cuspidi,Marijana Tadic,Guido Grassi
Cesare Cuspidi
Prevalence of Hypertension in Venezuela: A Systematic Review and Meta-Analysis [0.03%]
委内瑞拉高血压患病率的系统评价和meta分析
Juan Salazar,Roberto Añez,Soledad Briceño et al.
Juan Salazar et al.
There are no studies that quantitatively synthesize epidemiological data on hypertension (HT) in Venezuela. To systematically review and conduct a meta-analysis of population-based studies on the prevalence of HT in Venezuela. For this, a l...
Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring [0.03%]
基于家庭血压监测的血管紧张素受体脑啡肽酶抑制剂在不能耐受安博维治疗的高血压患者中的有效性和安全性：真实世界研究
Yoshio Iwashima,Masato Sugiura,Takeshi Horio et al.
Yoshio Iwashima et al.
This study assessed the efficacy and safety of sacubitril/valsartan in 27 essential hypertensive patients (mean age 74 years; male 48.1%) after switching from azilsartan, an angiotensin receptor blocker. At baseline and 3 and 6 months after...